Literature DB >> 25218762

In vitro effects of exercise on the heart.

Dane J Youtz1, Michael C Isfort2, Clayton M Eichenseer1, Timothy D Nelin2, Loren E Wold3.   

Abstract

Pathologic and physiologic factors acting on the heart can produce consistent pressure changes, volume overload, or increased cardiac output. These changes may then lead to cardiac remodeling, ultimately resulting in cardiac hypertrophy. Exercise can also induce hypertrophy, primarily physiologic in nature. To determine the mechanisms responsible for each type of remodeling, it is important to examine the heart at the functional unit, the cardiomyocyte. Tests of individual cardiomyocyte function in vitro provide a deeper understanding of the changes occurring within the heart during hypertrophy. Examination of cardiomyocyte function during exercise primarily follows one of two pathways: the addition of hypertrophic inducing agents in vitro to normal cardiomyocytes, or the use of trained animal models and isolating cells following the development of hypertrophy in vivo. Due to the short lifespan of adult cardiomyocytes, a proportionately scant amount of research exists involving the direct stimulation of cells in vitro to induce hypertrophy. These attempts provide the only current evidence, as it is difficult to gather extensive data demonstrating cell growth as a result of in vitro physical stimulation. Researchers have created ways to combine skeletal myocytes with cardiomyocytes to produce functional muscle cells used to repair pathologic heart tissue, but continue to struggle with the short lifespan of these cells. While there have been promising findings regarding the mechanisms that surround cardiac hypertrophy in vitro, the translation of in vitro findings to in vivo function is not consistent. Therefore, the focus of this review is to highlight recent studies that have investigated the effect of exercise on the heart, both in vitro and in vivo.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exercise; Heart; Hypertrophy; Myocyte; Signaling mechanisms

Mesh:

Year:  2014        PMID: 25218762      PMCID: PMC4252615          DOI: 10.1016/j.lfs.2014.08.015

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  48 in total

1.  Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.

Authors:  Masami Hiroyama; Shuyi Wang; Toshinori Aoyagi; Ryo Oikawa; Atsushi Sanbe; Satoshi Takeo; Akito Tanoue
Journal:  Eur J Pharmacol       Date:  2006-12-29       Impact factor: 4.432

Review 2.  Eccentric and concentric cardiac hypertrophy induced by exercise training: microRNAs and molecular determinants.

Authors:  T Fernandes; U P R Soci; E M Oliveira
Journal:  Braz J Med Biol Res       Date:  2011-09-02       Impact factor: 2.590

3.  Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice.

Authors:  Min Tian; Michelle L Asp; Yoshinori Nishijima; Martha A Belury
Journal:  Int J Oncol       Date:  2011-08-05       Impact factor: 5.650

4.  Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.

Authors:  Dao-Fu Dai; Simon C Johnson; Jason J Villarin; Michael T Chin; Madeline Nieves-Cintrón; Tony Chen; David J Marcinek; Gerald W Dorn; Y James Kang; Tomas A Prolla; Luis F Santana; Peter S Rabinovitch
Journal:  Circ Res       Date:  2011-02-10       Impact factor: 17.367

Review 5.  The PGC-1 cascade as a therapeutic target for heart failure.

Authors:  Joel Schilling; Daniel P Kelly
Journal:  J Mol Cell Cardiol       Date:  2010-10-01       Impact factor: 5.000

6.  Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

Authors:  S Jard; R C Gaillard; G Guillon; J Marie; P Schoenenberg; A F Muller; M Manning; W H Sawyer
Journal:  Mol Pharmacol       Date:  1986-08       Impact factor: 4.436

7.  Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.

Authors:  Asli F Ceylan-Isik; Maolong Dong; Yingmei Zhang; Feng Dong; Subat Turdi; Sreejayan Nair; Masashi Yanagisawa; Jun Ren
Journal:  Basic Res Cardiol       Date:  2013-02-05       Impact factor: 17.165

8.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

9.  Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes.

Authors:  Xiaohong Tracey Gan; Venkatesh Rajapurohitam; James V Haist; Peter Chidiac; Michael A Cook; Morris Karmazyn
Journal:  J Pharmacol Exp Ther       Date:  2004-09-27       Impact factor: 4.030

Review 10.  Left ventricular diastolic dysfunction and diastolic heart failure.

Authors:  William H Gaasch; Michael R Zile
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.